230 results
Page 3 of 12
8-K
EX-99.1
uhfbe7
6 May 21
Corcept Therapeutics Provides Clinical Update and Announces First Quarter 2021 Financial Results
4:17pm
8-K
EX-10.1
pkenc6o sopbz563
1 Mar 21
Departure of Directors or Certain Officers
5:16pm
8-K
EX-10.2
4h6ysx
1 Mar 21
Departure of Directors or Certain Officers
5:16pm
S-8
ey0vx50 pdj9
23 Feb 21
Registration of securities for employees
5:12pm
8-K
EX-99.1
b2pw84
23 Feb 21
Corcept Therapeutics Announces Fourth Quarter
4:14pm
8-K
EX-99.1
6597zpz56fb52ds
8 Feb 21
Full-year 2020 Preliminary Selected Financial Results
4:12pm
8-K
EX-99.1
15v0h05z28n
23 Nov 20
Corcept Therapeutics Appoints Gillian M. Cannon, PHD, to Board of Directors
5:24pm
8-K
EX-99.1
smiaq92g5 0xq3nv
19 Nov 20
U.S. Patent Trial and Appeals Board Affirms Validity
12:00am
8-K
EX-99.1
4hspb8
3 Nov 20
Corcept Therapeutics Announces Third Quarter 2020
4:12pm
8-K
EX-99.1
de40 1vwordhd0xdq7
4 Aug 20
Corcept Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
4:35pm